DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-146946 | Pharmaceuticals and Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Diagnosis of Autoimmune Diseases Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET
7.1 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DIAGNOSIS OF AUTOIMMUNE DISEASES MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Thermo Fisher Scientific
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Siemens
16.3 Inova Diagnostics
16.4 GRIFOLS
16.5 Danaher
16.6 Bio-Rad Laboratories
16.7 Abbott
16.8 Trinity Biotech
16.9 Werfen
16.10 Protagen
16.11 HYCOR Biomedical
16.12 HTG Molecular Diagnostics
16.13 EUROIMMUN AG
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeRoutine Laboratory Tests
Inflammatory Markers
Autoantibodies & Immunologic Test
Other Tests
By Application
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Sj?gren’s Syndrome
Thyroiditis
Scleroderma
Other Diseases
Companies
Thermo Fisher Scientific
Siemens
Inova Diagnostics
GRIFOLS
Danaher
Bio-Rad Laboratories
Abbott
Trinity Biotech
Werfen
Protagen
HYCOR Biomedical
HTG Molecular Diagnostics
EUROIMMUN AG
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.